Suppr超能文献

局部用非甾体抗炎药在乳腺疼痛治疗中的疗效。

Efficacy of topical nonsteroidal antiinflammatory drugs in mastalgia treatment.

作者信息

Colak Tahsin, Ipek Turgut, Kanik Arzu, Ogetman Zekai, Aydin Suha

机构信息

Department of General Surgery, Medical Faculty of Mersin University, 33079 Mersin/ICEL/Turkey.

出版信息

J Am Coll Surg. 2003 Apr;196(4):525-30. doi: 10.1016/S1072-7515(02)01893-8.

Abstract

BACKGROUND

The aim of the study was to investigate the effects of topical nonsteroidal antiinflammatory drugs (NSAIDs) on mastalgia.

STUDY DESIGN

A prospective, randomized, blinded, placebo-controlled study was performed to evaluate the effects of topical NSAIDs on cyclic and noncyclic mastalgia. A total of 108 patients, 60 with cyclic (group I) and 48 with noncyclic (group II) breast pain were enrolled. Patients within each group were randomly assigned to receive either topical NSAIDs or placebo three times daily for at least 6 months. Severity of pain was measured before and after 6 months of treatment.

RESULTS

The pain score decreased significantly when the mean initial breast pain score was compared with the sixth-month breast pain score of the treatment or the placebo group of cyclic (p = 0.0001 and p = 0.0001, respectively) or noncyclic mastalgia (p = 0.0001 and p = 0.0001, respectively). Significant differences were found when the mean within-person change in pain values in each treatment group were compared with the change in the respective placebo group for either cyclic or noncyclic mastalgia (p = 0.0001 and p = 0.0001, respectively). Changes in pain within treatment groups or placebo groups for cyclic versus noncyclic mastalgia were not found to be statistically different (p = 0.53 and p = 0.96, respectively). No side effect was seen in any group.

CONCLUSIONS

Topical application of NSAIDs was effective in both cyclic and noncyclic mastalgia with minimal side effects.

摘要

背景

本研究旨在调查外用非甾体抗炎药(NSAIDs)对乳腺疼痛的影响。

研究设计

进行了一项前瞻性、随机、双盲、安慰剂对照研究,以评估外用NSAIDs对周期性和非周期性乳腺疼痛的影响。共纳入108例患者,其中60例为周期性乳腺疼痛患者(I组),48例为非周期性乳腺疼痛患者(II组)。每组患者随机分配,每天接受3次外用NSAIDs或安慰剂治疗,至少持续6个月。在治疗6个月前后测量疼痛严重程度。

结果

将治疗组或安慰剂组的周期性(分别为p = 0.0001和p = 0.0001)或非周期性乳腺疼痛(分别为p = 0.0001和p = 0.0001)患者的初始乳腺疼痛平均评分与第6个月的乳腺疼痛评分进行比较时,疼痛评分显著降低。将每个治疗组疼痛值的平均个体内变化与相应安慰剂组的周期性或非周期性乳腺疼痛变化进行比较时,发现存在显著差异(分别为p = 并0.0001和p = 0.0001)。未发现周期性与非周期性乳腺疼痛的治疗组或安慰剂组内疼痛变化有统计学差异(分别为p = 0.53和p = 0.96)。任何组均未观察到副作用。

结论

外用NSAIDs对周期性和非周期性乳腺疼痛均有效,且副作用最小。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验